Renaissance Technologies
CKPT

Renaissance Technologies’s Checkpoint Therapeutics CKPT Stock Holding History

Renaissance Technologies’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-88,790
Closed -$199K – 3606
2024
Q3 		$199K Buy
88,790
+11,590
+15% +$26.7K ﹤0.01% 3130
2024
Q2 		$166K Sell
77,200
-194,017
-72% -$345K ﹤0.01% 3085
2024
Q1 		$556K Buy
271,217
+105,486
+64% +$210K ﹤0.01% 2815
2023
Q4 		$380K Buy
+165,731
New +$361K ﹤0.01% 2891
2022
Q4 		– Sell
-35,750
Closed -$372K – 4141
2022
Q3 		$372K Sell
35,750
-39,689
-53% -$473K ﹤0.01% 3089
2022
Q2 		$777K Sell
75,439
-16,865
-18% -$221K ﹤0.01% 2872
2022
Q1 		$1.63M Buy
92,304
+69,654
+308% +$1.5M ﹤0.01% 2380
2021
Q4 		$704K Buy
+22,650
New +$750K ﹤0.01% 2906
2021
Q1 		– Sell
-2,805
Closed -$74K – 3349
2020
Q4 		$74K Sell
2,805
-8,985
-76% -$227K ﹤0.01% 3290
2020
Q3 		$316K Buy
11,790
+1,640
+16% +$39.4K ﹤0.01% 2977
2020
Q2 		$201K Buy
10,150
+5,560
+121% +$101K ﹤0.01% 3158
2020
Q1 		$69K Sell
4,590
-7,280
-61% -$129K ﹤0.01% 3286
2019
Q4 		$204K Sell
11,870
-770
-6% -$12.9K ﹤0.01% 3195
2019
Q3 		$315K Sell
12,640
-1,430
-10% -$39.2K ﹤0.01% 3024
2019
Q2 		$426K Buy
14,070
+1,630
+13% +$64K ﹤0.01% 3064
2019
Q1 		$356K Buy
12,440
+940
+8% +$30K ﹤0.01% 3046
2018
Q4 		$209K Buy
11,500
+3,550
+45% +$84.5K ﹤0.01% 3122
2018
Q3 		$284K Buy
+7,950
New +$278K ﹤0.01% 3036

Other funds holding CKPT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Renaissance Technologies's CKPT Position: Q4 2024 in Review

Renaissance Technologies sold out of Checkpoint Therapeutics (CKPT) in Q4 2024, closing a stake of 88,790 shares — an estimated $199K sold.

Renaissance Technologies first reported a position in CKPT in Q3 2018 and held it in 18 quarters. The position peaked at $1.63M in Q1 2022. 68 funds tracked by Wall St. Rank hold CKPT as of Q4 2024.

  • Renaissance Technologies reported no remaining Checkpoint Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Renaissance Technologies sold 88,790 Checkpoint Therapeutics shares in Q4 2024, an estimated $199K.
  • Renaissance Technologies first reported a position in Checkpoint Therapeutics in Q3 2018 and held it in 18 quarters.
  • Renaissance Technologies's Checkpoint Therapeutics position peaked at $1.63M in Q1 2022.
  • 68 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q4 2024.

Based on Renaissance Technologies's 13F filing for Q4 2024, filed 13 Feb 2025.